Carole Ho Denali Therapeutics Inc. (DNLI) insider trading activity
Carole Ho is Chief Medical Officer of Denali Therapeutics Inc.. Currently has a direct ownership of 118,810 shares of DNLI, which is worth approximately $3.4 Million. The most recent transaction as insider was on Aug 21, 2024, when has been sold 20,005 shares (Common Stock) at a price of $24.68 per share, resulting in proceeds of $493,723. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
119K
17.27%
3M change
14.5%
12M change
Total Value Held
$3.4 Million
Carole Ho Transaction History
Also insider at
CH
Carole Ho
Chief Medical Officer
Cambridge, MA